Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What is relapse in schizophrenia?

M Lader1

  • 1Institute of Psychiatry, De Crespigny Park, London, UK.

International Clinical Psychopharmacology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Relapse in schizophrenia signifies a return of illness symptoms, impacting social and occupational functioning. Understanding relapse criteria is crucial for effective patient management and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A patient who changed my practice: Personality disorder or bipolar disorder?

International journal of psychiatry in clinical practice·2014
Same author

Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.

European psychiatry : the journal of the Association of European Psychiatrists·2012
Same author

Plasma concentrations of tricyclic antidepressive drugs.

British journal of clinical pharmacology·2012
Same author

Caffeine withdrawal symptoms and rate of metabolism.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Buspirone treatment as an aid to benzodiazepine withdrawal.

Journal of psychopharmacology (Oxford, England)·2012
Same author

A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety.

Journal of psychopharmacology (Oxford, England)·2012
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Relapse is defined as a return of disease after partial recovery.
  • This definition is directly applicable to schizophrenic disorder.
  • Relapse in schizophrenia impacts symptomatic, phenomenological, and behavioral levels, affecting interpersonal, social, and occupational spheres.

Purpose of the Study:

  • To explore the multifaceted nature of relapse in schizophrenia.
  • To discuss the implications of relapse for patients, families, and healthcare systems.
  • To review existing and potential criteria for evaluating schizophrenic relapse.

Main Methods:

  • Literature review and conceptual analysis of relapse in schizophrenia.
  • Examination of various indicators of relapse, including overt behaviors and subtle symptom changes.

Related Experiment Videos

  • Discussion of factors influencing relapse, such as pre-illness functioning and treatment efficacy.

    • Main Results:

    • No universally accepted criteria for schizophrenic relapse exist.
    • Commonly used indicators include violence, suicide, extreme psychotic behavior, and rehospitalization.
    • Subtler indicators like symptom worsening and prodromata are also relevant.
    • Relapse is a relative concept influenced by pre-illness state, functioning, relapse severity, new symptoms, and treatment effectiveness.

    Conclusions:

    • Relapse in schizophrenia is a complex phenomenon with broad implications.
    • A comprehensive assessment considering multiple factors is necessary for accurate relapse evaluation.
    • Further research is needed to validate predictive social factors for relapse.